Work

Early therapy for type 2 diabetes in China

Year: 2014

Type: article

Source: The Lancet Diabetes & Endocrinology

DOI: 10.1016/s2213-8587(14)70136-6

Authors: Wenying Yang, Jianping Weng

Institutions: China-Japan Friendship Hospital, Sun Yat-sen University, Third Affiliated Hospital of Sun Yat-sen University

Language: English

Topic: Diabetes Treatment and Management

Subfield: Endocrinology, Diabetes and Metabolism

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Science Foundation, Eli Lilly and Company, AstraZeneca, Bayer, Sanofi, Medtronic, National Natural Science Foundation of China, Novo Nordisk, Johnson and Johnson, China National Funds for Distinguished Young Scientists, National High-tech Research and Development Program

Awards: G166807028, G2915427969, G3954031997, G6590310734, G8942335587

OpenAlex ID: W1991221305

FWCI: 4.429

Cites: 86

Cited by: 52

Related to: 10